Treatment with the identified compound caused a highly significant reduction in the levels of total ROS as indicated by a decrease in CellROX immunolabeling thereby effectively blocking the oxidative stress pathway.
← all excerpts
Evaluating the Efficacy of Taurodeoxycholic Acid in Providing Otoprotection Using an <i>in vitro</i> Model of Electrode Insertion Trauma.
1
—
—